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Spectrofluorimetric method for atenolol determination 
based on gold nanoparticles
A simple and sensitive spectrofluorimetric method for deter-
mination of atenolol (ATE) using gold nanoparticles (AuNPs) 
was developed. The method is based on the quench ing effect 
of atenolol on photoluminescence of AuNPs at lem = 705 nm. 
Variables affecting luminescence of gold nanoparticles 
such as the solvent, pH value and surfactant were studied 
and optimized. The method was preliminarily validated 
according to ICH guidelines. A linear correlation was re-
corded within the range of 1.0–10 mg mL–1 ATE with the 
coefficient of determination R2 of 0.999. The limit of detec-
tion and limit of quantitation for atenolol were found to be 
0.87 and 2.64 mg mL–1, resp. Good recoveries in the range of 
98.7–100.0 % were obtained for spiked samples. The propos ed 
method was applied successfully to assaying atenolol in 
pharmaceuticals formulations.
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Atenolol, 4-(2-hydroxy-3-isopropylaminopropoxy)phenylacetamide (ATE), is a beta-
blocker that affects the heart and circulation. Atenolol is used to treat angina and hyper-
tension. Atenolol is also used to lower the risk of death after a heart attack (1).
Previous studies applied spectrofluorimetry to estimation of atenolol in aqueous solu-
tions and samples of human urine because of its sensitivity, selectivity and low-cost instru-
mentation (2). Fluorescence was used to detect atenolol without and with solid-phase ex-
traction (3). Photoluminescence of metal nanoparticles that offer emission of light without 
requiring conjugation with luminous dyes is the basis for the new method (4).
The photo-physical properties of colloidal gold nanoparticles are unique in showing 
stable and non-bleaching fluorescence, which was already widely used in a variety of 
molecularly targeted biological applications, including multiphoton and correlative mi-
croscopy (5). In this study, novel, simple, sensitive and selective gold nanoparticles (AuNPs) 
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Atenolol, gold(III) chloride trihydrate (HAuCl4), cetyl-trimethyl-ammonium bromide 
(CTAB), sodium dodecyl sulfate (SDS) surfactant and HPLC grade solvents such as metha-
nol, acetonitrile (ACN) and dimethylsulphoxide (DMSO) were purchased from Sigma Al-
drich (USA). A commercial pharmaceutical formulation (Normoten-100, Jazeera Pharma-
ceutical Industries, Saudi Arabia) was used.
Synthesis and physical characterization of gold nanoparticles
Gold nanoparticles were synthesized by the citrate reduction method according to the 
reported method (6).
Absorption and photo-luminescence spectra were measured on spectrophotometer 
and spectrofluorimeter models USB4000 and USB4000FL, resp. (Ocean Optics Devices, 
USA). Diameter and colloidal properties of gold nanoparticles were estimated using scan-
ning electron microscopy (SEM) on a Phillips CM201C microscope at 80 kV (Phillips, The 
Netherlands).
ATE standard solutions and calibration
An accurately weighed amount of ATE was dissolved in methanol to get a stock solu-
tion of 50 µg mL–1. Working ATE solutions in the concentration range of 1–10 µg mL–1 were 
transferred into a series of 10-mL calibrated flasks containing 300 µL of 0.277 mmol L–1 
colloidal AuNPs.
Procedure for commercial tablets
Fine powder of Normoten-100 tablets (equivalent to 100 mg of atenolol) was accu-
rately weighed and placed in a 100-mL flask containing methanol. The solution was soni-
cated, filtered and then made up with methanol to 10 µg mL–1 of atenolol.
Quenching of photoluminescent AuNPs by ATE
The Stern-Volmer relationship was explored for the kinetics of photo-physical inter-
molecular deactivation of photoluminescent AuNPs by atenolol according to:





where I0 and I are luminescence intensity of AuNPs in the absence and in the presence of 
different atenolol concentrations at lem = 705 nm, [Q] is the concentration of the quencher 
and KSV is the Stern-Volmer constant as a measure of sensor sensitivity (7).
Method validation
Validation of the method was done according to the ICH Q2 (R1) guideline (8).
Linearity and range. – Linearity was established from the calibration curve of photolu-
minescence of AuNPs vs. atenolol concentration estimating R2. Limits of detection and 
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quantitation (LOD and LOQ, resp.) for the proposed method were evaluated as per ICH 
guidelines using the formulae:
 LOD = 3.3 s / S and LOQ = 10 s / S
where s is standard deviation of the response (standard deviation of y-intercepts of the 
regression line), S is the slope of the calibration line.
Precision and accuracy. – Intra-day and inter-day precision were investigated by evalu-
ating 3 sample replicates on the same day and on 3 different days of a week. Results are 
expressed as RSD.
Accuracy was established as the percent of recovery of ATE for three standard addi-
tions to the sample. Three different concentrations were added to a fixed amount of the 
prepared drug sample, standard Normoten, and the total was analyzed by the studied 
method. Each analysis was carried out three times.
Specificity. – Specificity of the method for atenolol was evaluated in the presence of 
interfering substances such as excipients, degradants and matrix components (starch, lac-
tose, glucose and sodium chloride). Excipient concentrations were 5, 10 and 20 µg mL–1 
mixed with a fixed concentration of atenolol (5 µg mL–1).
Robustness. – For the determination of method robustness, three factors were exam-
ined: reaction time, change of temperature and change of the order of reagent addition.
RESULTS AND DISCUSSION
Diameter of AuNPs
AuNPs appeared as small dark spherical dots. Fig. 1 shows the SEM images of AuNPs, 
which reveal that the average size of AuNPs with the shape of nanoclusters was 22.8 ± 8.0 nm.
Fig. 1. SEM image of AuNPs prepared by the citrate reduction method in DMSO.
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Factors affecting AuNP luminescence
Solvent effect. – The absorption and luminescence spectra are shown in Fig 2. Absor-
bance of Au nanoparticles at 525 nm decreased whenever the dipole moment of the solvent 
decreased. The gold nanoparticles aggregated and flocculated at room temperature in a 
nonpolar solvent such as cyclohexane while the strength of solvent polarity maintained 
the AuNP particles in suspension form.
In the case of protic solvents, the absorbance of AuNPs is slightly red-shifted as the 
polarity decreases. This might be attributed to the electrostatic interaction of the solvent 
OH group with AuNP citrate capping. In the case of acetonitrile, the absorbance is also 
red-shifted. It is worth noting that the peak in this case is shown to be broad. In the case 
of CAN, the AuNPs appear to be aggregated, since ACN has low affinity towards AuNPs 
(9). In the case of DMSO, the sulfuric group can envelope AuNPs as a further protection 
layer, resulting in the lowest quenching of AuNP luminescence (10).
Effect of pH. – The absorbance and photoluminescence of colloidal AuNP dispersions 
was measured at different pH values (4–10). At pH ≤ 4, the negative charge of citrate anions 
surrounding the gold nanoparticles became fully protonated and the Au nanoparticles 
were aggregated; hence the stability of the suspension form decreased. At pH ≥ 10.0, the 
gold nanoparticle surface was fully deprotonated and their stability was improved (11).
Effect of KCl solution. – The absorbance and photoluminescence properties of AuNPs 
were measured at 635 nm using different concentrations of KCl (0.1–1.00 mmol L–1). At low 
ionic strength, small aggregates were formed of gold nanoparticles, which were stable over 
a long period of time. We found that the AuNPs showed faster aggregation and precipita-
tion at 0.6 mmol L–1 KCl (12).
Effect of surfactant. – The absorption band of gold nanoparticles was affected by different 
concentrations of CTAB (10–50 mmol L–1) and SDS (10–50 mmol L–1). The AuNPs aggregated 
at 10 mmol L–1 of cationic CTAB micelles due to the strong interaction of the cationic head group 
Fig. 2. Absorption and photoluminescence spectra of AuNPs using different solvents.
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of CTAB micelles with citrate capping of AuNPs. At higher concentrations (> 10 mmol L–1), 
the AuNPs became more stable because the CTAB micelles formed a bilayer over citrate 
capped AuNPs. In the case of 10 mmol L–1 of anionic SDS, the AuNPs did not aggregate 
due to the electrostatic repulsion between the negative head group (-OSO3
–) and citrate 
capping on AuNPs. AuNPs were stabilized at > 10 mmol L–1 of SDS micelles since the SDS 
micelles adsorbed on the surface of citrate-capped AuNPs (13).
Analytical validation
Linearity. – The calibration line was established in the range of 0.1–10 µg mL–1 ATE, 
R2 = 0.9998. Table I shows the LOD and LOQ values of 0.87 and 2.64 µg mL–1 ATE, resp.
Sensitivity and stability. – The high value of molar absorptivity (ε) and low values of 
LOD/LOQ indicate high sensitivity of the proposed method, as shown from Table I. The 
luminescence intensity of AuNPs was stable for 24 h. Using the spike standard, namely, 
after adding atenolol, recovery of luminescence of AuNPs-ATE was 99.5 ± 0.01 % (mean ± SD, 
n = 3) and the RSD value was less than 1 %. The luminescence of AuNPs-ATE was  measured 
at time intervals of 1, 10 and 60 min and the temperature intervals were 20, 30 and 40 °C.
Accuracy and precision. – Table II shows the accuracy and precision of the proposed 
method. RSD was ≤ 2.0 % (intra-day) and ≤ 0.4 % (inter-day). In addition, the accuracy of 
the proposed method was measured by calculating the percent relative error, which varied 
Table I. Sensitivity and regression parameters for atenolol by AuNPs as a photo probe
Analyte Atenolol 
Wavelength (nm) 705 nm
Beer’s law limits (mg mL–1) 1–10
Regression equation y = a + bx (a = 0.0346, b = 1.0012)
Coefficient of determination (R2) 0.999
LOD (mg mL–1) 0.87
LOQ (mg mL–1) 2.64
Molar absorptivity (e, L moL–1 cm–1) 3.7 × 102
RSD (%) 1.2













0.100 0.102 2.0 102.0 ± 1.0 0.103 0.3 101.0 ± 0.4
2.700 2.690 0.4 99.6 ± 1.0 2.720 0.4 101.1 ± 0.4
7.000 7.010 0.3 100.1 ± 1.0 7.020 0.1 100.1 ± 0.4
ATE – atenolol
* Recovery (%); mean ± SD, n = 3.
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between 0.1 and 2.5 %, and the recovery was 99.6–102.0 % according to the standard addi-
tion method. Results presented in Table II reveal a slight effect on the accuracy of the 
method in various excipients.
Robustness. – The average value of ATE recovery was 99.5 ± 0.01 % using standard ad-
ditions (mean ± SD, n = 3) and the RSD value was less than 1 %. This means that the pro-
posed method is robust with small variations in temperature (20, 30 and 40 °C) and time 
intervals (1, 10 and 60 min).
Specificity. – Recovery of atenolol was found in the range 99.0–101.0 % with RSD < 2 % 
using the standard addition method.
Analysis of the commercial formulation
The proposed method was successfully applied to determination of ATE in the Nor-
moten-100 formulation. The results are given in Table III.
Table IV shows the data obtained by the proposed method compared to reference 
methods (14, 15). Recovery of ATE in Normoten (100 mg ATE) by the proposed method was 











3.00 0.00 2.99 99.7 ± 0.1
3.00 0.50 3.51 98.0 ± 2.0
3.00 3.00 5.99 99.7 ± 0.3
3.00 5.00 7.99 99.8 ± 0.2
a Mean ± SD, n = 3.











Oxidation of drug using 
alkaline KMnO4 (13)
Blokium 100.0 ± 0.5
2.0–14.0/ 
0.081
Less sensitive under 
heating
Reaction with Phenol Red 
in acidic medium (14)




Quenching of luminescence 
of AuNPs by atenolol 
(proposed method)
Normoten 100.2 ± 0.3
2.6–10/ 
0.870
Simple, no heating, short 
response time, stable 
luminescent reagent
a Recovery ± RSD, n = 3.
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100.2 ± 0.3 % (mean ± SD, n = 3). The advantages of this method compared to reference 
methods was that the proposed method had a short response time, ~5 s, and that the AuNP 
luminescence was stable, ~60 min.
CONCLUSIONS
A simple, sensitive, accurate and precise spectrofluorimetric method using AuNPs as 
a photo probe is suggested for determination of atenolol. The luminescence intensity of 
AuNPs in different solvents, at different pH values, at different KCl concentrations and in 
the presence of two types of surfactants was studied to obtain optimum conditions. The 
proposed method can be used for routine analysis of atenolol in pharmaceutical dosage 
forms.
Acknowledgments. – The authors are grateful to the Dean of Scientific Research at King Faisal 
University for financial support for project no. 140255.
REFERENCES
 1.  J. G. Hardman, L. E. Limbird and A. G. Gilman, Goodman and Gilman’s The Pharmacological Basis of 
Therapeutics, 10th ed., McGraw-Hill, New York, 2001, 1011–1021.
 2.  F. Belal, S. Al-Shaboury and A. Al-Tamrah, Spectrofluorometric determination of labetolol in 
pharmaceutical preparations and spiked human urine through the formation of coumarin de-
rivative, J. Pharm. Biomed. Anal. 30 (2002) 1191–1196; https://doi.org/10.1016/s0731-7085(02)00471-5
 3.  H. Basan and S. Yarımkaya, A novel solid-phase extraction-spectrofluorimetric method for the 
direct determination of atenolol in human urine, Luminescence 29 (2013) 225–229; https://doi.
org/10.1002/bio.2532
 4.  A. Bavili-Tabrizi, F. Bahrami and H. Badrouj, A very simple and sensitive spectrofluorimetric 
method based on the oxidation with cerium(IV) for the determination of four different drugs in 
their pharmaceutical formulations, Pharm. Sci. 23 (2017) 50–58; https://doi.org/10.15171/ps.2017.08
 5.  Y. Jiang, N. N. Horimoto, K. Imura, H. Okamoto, K. Matsui and R. Shigemoto, Bioimaging with 
two-photon-induced luminescence from triangular nanoplates and nanoparticle aggregates of 
gold, Adv. Mat. 21 (2009) 2309–2313; https://doi.org/10.1002/adma.200802312
 6.  A. D. McFarland, C. L. Haynes, C. A. Mirkin, R. P. V. Duyne and H. A. Godwin, Color my nano-
world, J. Chem. Ed. 81 (2004) 544A–544B; https://doi.org/10.1021/ed081p544a
 7.  O. Stern and M. Volmer, Decay of fluorescence, J. Röntgen Soc. 15 (1919) 133–133; https://doi.
org/10.1259/lrs.1919.0087
 8.  International Conference on Harmonisation of Technical Requirements for Registration of Phar-
maceuticals for Human Use, ICH Harmonised Tripartite Guideline, Validation of Analytical Procedures: 
Text and Methodology Q2(R1), Current Step 4 version, November 2005; https://www.ich.org/filead-
min/Public_Web_Site/ICH_Products/Guidelines/Quality/Q2_R1/Step4 /Q2_R1_Guideline.pdf; 
last access date Dec 11, 2017.
 9.  K. G. Thomas, B. I. Ipe and P. K. Sudeep, Photochemistry of chromophore-functionalized gold 
nanoparticles, Pure Appl. Chem. 74 (2002) 1731–1738; https:// doi.org/10.1351/pac200274091731
10.  V. Amendola, G. A. Rizzi, S. Polizzi and M. Meneghetti, Synthesis of gold nanoparticles by laser 
ablation in toluene: quenching and recovery of the surface plasmon absorption, J. Phys. Chem. 
B 109 (2005) 23125–23128; https://doi.org/10.1021/jp055783v
250
E. Bakir et al.: Spectrofluorimetric method for atenolol determinationbased on gold nanoparticles, Acta Pharm. 68 (2018) 243–250.
 
11.  K. Wagers, T. Chui and S. Adem, Effect of pH on the stability of gold nanoparticles and their ap-
plication for melamine detection in infant formula, IOSR J. Appl. Chem. 7 (2014) 15–20; https://doi.
org/10.9790/5736-07821520
12.  R. Pamies, J. G. H. Cifre, V. F. Espín, M. Collado-González, F. G. D. Baños and J. G. de la Torre, 
Aggregation behaviour of gold nanoparticles in saline aqueous media, J. Nanopart. Res. 16 (2014) 
Article ID 2376 (11 pages); https://doi.org/10.1007/s11051-014-2376-4
13.  J. Lim, N.-E. Lee, E. Lee and S. Yoon, Surface modification of citrate-capped gold nanoparticles 
using CTAB micelles, Bull. Kor. Chem. Soc. 35 (2014) 2567–2569; https://doi.org 10.5012/
bkcs.2014.35.8.25674
14.  A. M. El-Didamony and M. A. Moustafa, Direct spectrophotometric determination of atenolol and 
timolol anti-hypertensive drugs, Int. J. Pharm. Pharm. Sci. 9 (2017) 47–53; https://doi.org/10.22159/
ijpps.2017v9i3.16198
15.  I. E. H. Elgailani and T. H. Alghamdi, Development of spectrophotometric method for the deter-
mination of atenolol in Normoten drug, Int. J. Chem. 9 (2017) 58–64; https://doi.org/0.5539/ijc.
v9n1p58
